GLOBAL INJECTABLE DRUG DELIVERY MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL INJECTABLE DRUG DELIVERY MARKET FORECAST 2019-2027

GLOBAL INJECTABLE DRUG DELIVERY MARKET FORECAST 2019-2027

The global injectable drug delivery market is anticipated to grow at a CAGR of 8.73% between 2019 and 2027. Injectable delivery systems directly inject or administer the drug into the body of the patient apart from the oral route. The important drivers increasing growth in the global injectable drug delivery market are growing elderly population and rising prevalence of autoimmune diseases. Worldwide, the population of older people (65 years & above) is expected to grow by 60% in the next 15 years. 

GLOBAL INJECTABLE DRUG DELIVERY MARKET FORECAST 2018-2026

Global Injectable Drug Delivery Market by Routes of Administration (Subcutaneous, Intramuscular, Intravenous (Iv), Other (Intra Peritoneal, Intra‐arterial, Etc.)), by End User (Clinics/ Physician Offices, Ambulatory Care, Hospital, Home Based and Other End Users), by Device Types (Pen Injectors, Auto‐injector, Needle Free Injectors, Prefilled Syringes) & by Geography.

Request free sample

The global injectable drug delivery market is anticipated to grow at a CAGR of 8.73% between 2019 and 2027. Injectable delivery systems directly inject or administer the drug into the body of the patient apart from the oral route.

The Injectable drug delivery market is primarily driven by the following factors:

  • Rising prevalence of autoimmune diseases
  • Advancement in technology
  • Growing elderly population
  • Widespread adoption of self-administered medications and services

To learn more about this report, request a free sample copy

The important drivers increasing growth in the global injectable drug delivery market are growing elderly population and rising prevalence of autoimmune diseases. Worldwide, the population of older people (65 years & above) is expected to grow by 60% in the next 15 years. Therefore, by 2030, the population of older people is expected to be about 1 billion, which would be 12% of the total world population. Exposure to chemicals and radiations, genetic mutations, and degrading environmental quality are some of the other causative factors which may lead to various autoimmune disorders.

Device types are very crucial to the injectable drug delivery market. Pen injectors consist of cartridges or chambers that are filled with medication and hence are called prefilled systems. Based on the chambers, they can be classified as single chambered and dual chambered. Auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The position of the injection depends on the drug-laden, but it usually is directed into buttocks or the thigh. The needle-free injectors market is expected to grow in future because of the technological advancements in the field as well as the advantages of the device over needle based systems. The needle-free injectors comprise of, spring‐based needle‐free Injectors, gas‐based needle‐free injectors and other needle-free injectors (laser‐powered and vibration based). Prefilled injectors are segmented into glass prefilled syringes and plastic prefilled syringes.

Stringent regulations and the high cost of manufacturing are the major factors hindering the injectable drug delivery market. Due to safety issues such as over or underuse of medication, missed or delayed therapy and medication errors, strict product regulations to govern these systems are in place. The automatic injection and retractable needle platform although provide advanced safety features, but in contrast, provides a cost burden both to the manufacturer and buyers.

The global injectable drug delivery market segments include device types, end user and routes of administration.

  • Device types are segmented into:
    • Pen injectors
    • Auto‐injector
    • Needle-free injectors
      • Gas‐based needle‐free injectors
      • Spring‐based needle‐free injectors
      • Other (laser‐powered and vibration based)
    • Prefilled syringes
      • Plastic prefilled syringes
      • Glass prefilled syringes
        • Dual chamber prefilled syringes
        • Single chambered prefilled syringes
      • End User is segmented into:
        • Clinics/ physician offices
        • Ambulatory care
        • Hospital
        • Home based
        • Others end users
      • Routes of Administration are segmented into:
        • Subcutaneous
        • Intramuscular
        • Intravenous (iv)
        • Other (intraperitoneal, intra‐arterial, etc.)

This report covered the present market conditions and the growth prospects of the global injectable drug delivery market for 2019-2027 and considered the revenue generated through the sales of injectable drug delivery for device types, end user and routes of administration to calculate the market size by considering 2018 as the base year.

Geographically, the global injectable drug delivery market has been segmented on the basis of four major regions, which include:

  • Injectable Drug Delivery North America Market: The United States & Canada
  • Injectable Drug Delivery Asia-Pacific Market: China, India, Japan, Australia, South Korea & Rest of APAC
  • Injectable Drug Delivery Europe Market: The United Kingdom, France, Germany, Spain, Italy & Rest of Europe
  • Rest of World: Latin America & the Middle East and Africa

The injectable drug delivery market in North America is expected to hold the largest share by 2027 possibilities of rising in the incidence of various chronic diseases such as cancer, diabetes, and arthritis which requires frequent drug dosing is expected to encourage patients towards self‐administration, which will, in turn, boost the uptake of prefilled syringes as well as other injection devices like auto‐injectors and pen injectors. On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the injectable drug delivery market. The Asia Pacific region is witnessing rising incidence of chronic diseases as well as an increase in the elderly population. The increased healthcare expenditure combined with the rising income of the population is another factor that is driving the higher demand for better healthcare products which is driving the injectable drug delivery market.

The injectable drug delivery market is segmented based on end user which is sub-divided into clinics/ physician offices, ambulatory care, hospital, home-based and others (rehab, nursing homes, etc.) and also segmented on the basis of routes of administration which are sub-divided into subcutaneous, intramuscular, intravenous and other (intraperitoneal, intra‐arterial, etc.). Subcutaneous refers to under the skin layer. The medication is injected into the layers of tissue between the skin and muscles. The intramuscular route of administration involves the administration of the medication into the muscles. Other routes include intracardiac, intraperitoneal, intradermal, intrathecal epidural and many others depending on the site of administration. Ambulatory centres are medical care centres that provide medical health facilities on an outpatient basis including the diagnosis and treatment. Home care settings are considered to be the largest end-user segment for injectable drug delivery system.

The major market players of the global Injectable drug delivery market are:

  • BECTON, DICKINSON & COMPANY (BD)
  • ELI LILLY AND COMPANY
  • GERRESHEIMER AG
  • NOVO NORDISK A/S
  • SCHOTT AG

The medical segment of BD produces an array of medical technologies and devices that are used in a range of healthcare settings. The medical segment consists of four business units, namely, diabetes care, medication and procedural solutions, medication management solutions, and pharmaceutical systems. SCHOTT AG operates into many industries, including the home appliance, pharmaceutical, electronics, life sciences, automotive and aviation industries and optics. SCHOTT has operations in more than 35 countries across North America, South America, Europe, Asia/Oceania, and the Middle East/ North Africa.

Key Findings of the Global Injectable drug delivery market:

  • Pen injectors device types hold the largest market share
  • The home-based end user is dominating the market
  • Subcutaneous routes of administration are majorly used
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • PEN INJECTORS DEVICE TYPES HOLDS THE LARGEST MARKET SHARE
      • HOME BASED END USER IS DOMINATING THE MARKET
      • SUBCUTANEOUS ROUTES OF ADMINISTRATION IS MAJORLY USED
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • RISING PREVALENCE OF AUTOIMMUNE DISEASES
      • ADVANCEMENT IN TECHNOLOGY
      • GROWING ELDERLY POPULATION
      • WIDESPREAD ADOPTION OF SELF‐ADMINISTERED MEDICATIONS AND SERVICES
    • MARKET RESTRAINTS
      • STRINGENT REGULATIONS
      • HIGH COST OF MANUFACTURING
    • MARKET OPPORTUNITIES
      • BETTER INJECTABLE DEVELOPMENT
      • CARE RISING HEALTHCARE EXPENDITURE
    • MARKET CHALLENGES
      • ALTERNATIVE DRUG DELIVERY TECHNOLOGY
  1. MARKET SEGMENTATION
    • MARKET BY ROUTES OF ADMINISTRATION 2019-2027
      • SUBCUTANEOUS
      • INTRAMUSCULAR
      • INTRAVENOUS (IV)
      • OTHER (INTRA PERITONEAL, INTRA‐ARTERIAL, ETC.)
    • MARKET BY END USER 2019-2027
      • CLINICS/ PHYSICIAN OFFICES
      • AMBULATORY CARE
      • HOSPITAL
      • HOME BASED
      • OTHERS END USERS
    • MARKET BY DEVICE TYPES 2019-2027
      • PEN INJECTORS
      • AUTO‐INJECTOR
      • NEEDLE FREE INJECTORS
        • GAS‐BASED NEEDLE‐FREE INJECTORS
        • SPRING‐BASED NEEDLE‐FREE INJECTORS
        • OTHER (LASER‐POWERED AND VIBRATION BASED)
      • PREFILLED SYRINGES
        • GLASS PREFILLED SYRINGES
          • SINGLE CHAMBERED PREFILLED SYRINGES
          • DUAL CHAMBER PREFILLED SYRINGES
        • PLASTIC PREFILLED SYRINGES
  1. KEY ANALYTICAL
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANT
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • PATENT ANALYSIS
    • LEGAL REQUIREMENT
    • REGULATORY FRAMEWORK
    • KEY BUYING CRITERIA
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • AUSTRALIA
      • INDIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPANY PROFILES
    • COMPETITIVE LANDSCAPE
      • MARKET SHARE ANALYSIS
    • BAXTER INTERNATIONAL INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • BECTON, DICKINSON & COMPANY (BD)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • ELCAM MEDICAL
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • ELI LILLY AND COMPANY
      • COMPANY OVERVIEW
      • PRODUCTS PORTFOLIO
      • SWOT ANALYSIS
      • STRATEGIC INITIATIVES
    • GERRESHEIMER AG
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • INJEX PHARMA GMBH
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • NOVARTIS INTERNATIONAL AG
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • NOVO NORDISK A/S
      • COMPANY OVERVIEW
      • PRODUCTS PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • SANOFI
      • COMPANY OVERVIEW
      • PRODUCTS PORTFOLIO
      • SWOT ANALYSIS
      • STRATEGIC INITIATIVES
    • TERUMO CORPORATION
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVE
    • SCHOTT AG
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • TEVA PHARMACEUTICALS
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • WEST PHARMACEUTICALS
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES

LIST OF TABLES

TABLE  1      GLOBAL INJECTABLE DRUG DELIVERY MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE  2      GLOBAL INJECTABLE DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION 2019-2027 ($ MILLION)

TABLE  3      GLOBAL INJECTABLE DRUG DELIVERY MARKET BY END USER 2019-2027 ($ MILLION)

TABLE  4      GLOBAL INJECTABLE DRUG DELIVERY MARKET BY END USER 2019-2027 ($ MILLION)

TABLE  5      GLOBAL INJECTABLE DRUG DELIVERY MARKET IN PEN INJECTORS BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE  6      DIFFERENT TYPES OF INSULIN PEN INJECTORS

TABLE  7      GLOBAL INJECTABLE DRUG DELIVERY MARKET IN PEN INJECTORS BY END USER 2019-2027 ($ MILLION)

TABLE  8      GLOBAL INJECTABLE DRUG DELIVERY MARKET IN AUTO‐INJECTOR BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE  9      GLOBAL INJECTABLE DRUG DELIVERY MARKET IN AUTO‐INJECTOR BY END USER 2019-2027 ($ MILLION)

TABLE  10    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN NEEDLE FREE INJECTORS BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE  11    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN NEEDLE FREE INJECTORS BY END USER 2019-2027 ($ MILLION)

TABLE  12    MARKETED NEEDLE FREE INJECTORS PRODUCTS

TABLE  13    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN NEEDLE FREE INJECTORS BY TYPES 2019-2027 ($ MILLION)

TABLE  14    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN PREFILLED SYRINGES BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE  15    LYOPHILIZED DRUGS WHICH ARE USED IN PREFILLED SYRINGE

TABLE  16    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN PREFILLED SYRINGES BY END USER 2019-2027 ($ MILLION)

TABLE  17    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN PREFILLED SYRINGES BY TYPES  2019-2027 ($ MILLION)

TABLE  18    GLOBAL PREFILLED SYRINGES MARKET IN GLASS PREFILLED SYRINGES BY TYPES  2019-2027 ($ MILLION)

TABLE  19    DUAL CHAMBERED PREFILLED SYRINGES DEVICES

TABLE  20    GLOBAL INJECTABLE DRUG DELIVERY MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE  21    NORTH AMERICA  INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

TABLE  22    THE UNITED STATES INJECTABLE DRUG DELIVERY MARKET BY DEVICE TYPES 2019-2027 ($ MILLION)

TABLE  23    CANADA INJECTABLE DRUG DELIVERY MARKET BY DEVICE TYPE 2019-2027 ($ MILLION)

TABLE  24    EUROPE INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

TABLE  25    THE UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET BY DEVICES TYPE 2019-2027 ($ MILLION)

TABLE  26    GERMANY INJECTABLE DRUG DELIVERY MARKET BY DEVICES TYPE 2019-2027 ($ MILLION)

TABLE  27    FRANCE INJECTABLE DRUG DELIVERY MARKET BY DEVICES TYPE 2019-2027 ($ MILLION)

TABLE  28    ITALY INJECTABLE DRUG DELIVERY MARKET BY DEVICES TYPE 2019-2027 ($ MILLION)

TABLE  29    SPAIN INJECTABLE DRUG DELIVERY MARKET BY DEVICES TYPE 2019-2027 ($ MILLION)

TABLE  30    ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

TABLE  31    JAPAN INJECTABLE DRUG DELIVERY MARKET BY DEVICES TYPE 2019-2027 ($ MILLION)

TABLE  32    CHINA INJECTABLE DRUG DELIVERY MARKET BY DEVICES TYPE 2019-2027 ($ MILLION)

TABLE  33    AUSTRALIA INJECTABLE DRUG DELIVERY MARKET BY DEVICES TYPE 2019-2027 ($ MILLION)

TABLE  34    INDIA INJECTABLE DRUG DELIVERY MARKET BY DEVICES TYPE 2019-2027 ($ MILLION)

TABLE  35    SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET BY DEVICES TYPE 2019-2027 ($ MILLION)

TABLE  36    REST OF WORLD INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE  1    GLOBAL INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  2    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN  SUBCUTANEOUS 2019-2027 ($ MILLION)

FIGURE  3    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN INTRAMUSCULAR  2019-2027 ($ MILLION)

FIGURE  4    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN INTRAVENOUS  2019-2027 ($ MILLION)

FIGURE  5    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN OTHER (INTRA PERITONEAL, INTRA‐ARTERIAL, ETC.) 2019-2027 ($ MILLION)

FIGURE  6    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN CLINICS/ PHYSICIAN OFFICES 2019-2027 ($ MILLION)

FIGURE  7    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN AMBULATORY CARE 2019-2027 ($ MILLION)

FIGURE  8    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN HOSPITAL 2019-2027 ($ MILLION)

FIGURE  9    GLOBAL INJECTABLE DRUG DELIVERY MARKET IN HOME BASED 2019-2027 ($ MILLION)

FIGURE  10  GLOBAL INJECTABLE DRUG DELIVERY MARKET IN OTHER END USERS 2019-2027 ($ MILLION)

FIGURE  11  GLOBAL NEEDLE FREE INJECTORS MARKET IN GAS‐BASED NEEDLE‐FREE INJECTORS 2019-2027 ($ MILLION)

FIGURE  12  GLOBAL NEEDLE FREE INJECTORS MARKET IN SPRING‐BASED NEEDLE‐FREE INJECTORS 2019-2027 ($ MILLION)

FIGURE  13  GLOBAL NEEDLE FREE INJECTORS MARKET IN OTHER (LASER‐POWERED AND VIBRATION BASED) 2019-2027 ($ MILLION)

FIGURE  14  GLOBAL PREFILLED SYRINGES MARKET IN GLASS PREFILLED SYRINGES 2019-2027 ($ MILLION)

FIGURE  15  GLOBAL GLASS PREFILLED SYRINGES MARKET IN SINGLE CHAMBERED PREFILLED SYRINGES 2019-2027 ($ MILLION)

FIGURE  16  GLOBAL GLASS PREFILLED SYRINGES MARKET IN DUAL CHAMBER PREFILLED SYRINGES 2019-2027 ($ MILLION)

FIGURE  17  GLOBAL PREFILLED SYRINGES MARKET IN PLASTIC PREFILLED SYRINGES 2019-2027 ($ MILLION)

FIGURE  18  THE UNITED STATES INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  19  CANADA INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  20  THE UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  21  GERMANY INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  22  FRANCE INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  23  ITALY INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  24  SPAIN INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  25  REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  26  JAPAN INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  27  CHINA INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  28  AUSTRALIA INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  29  INDIA INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  30  SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  31  REST OF ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  32  LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  33  MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET 2019-2027 ($ MILLION)

FIGURE  34  COMPANY MARKET SHARE ANALYSIS IN PEN AND AUTO INJECTORS MARKET 2017 (%)

FIGURE  35  COMPANY MARKET SHARE ANALYSIS IN PREFILLED MARKET 2017 (%)

  1. MARKET SEGMENTATION
    • MARKET BY ROUTES OF ADMINISTRATION 2019-2027
      • SUBCUTANEOUS
      • INTRAMUSCULAR
      • INTRAVENOUS (IV)
      • OTHER (INTRA PERITONEAL, INTRA‐ARTERIAL, ETC.)
    • MARKET BY END USER 2019-2027
      • CLINICS/ PHYSICIAN OFFICES
      • AMBULATORY CARE
      • HOSPITAL
      • HOME BASED
      • OTHERS END USERS
    • MARKET BY DEVICE TYPES 2019-2027
      • PEN INJECTORS
      • AUTO‐INJECTOR
      • NEEDLE FREE INJECTORS
        • GAS‐BASED NEEDLE‐FREE INJECTORS
        • SPRING‐BASED NEEDLE‐FREE INJECTORS
        • OTHER (LASER‐POWERED AND VIBRATION BASED)
      • PREFILLED SYRINGES
        • GLASS PREFILLED SYRINGES
          • SINGLE CHAMBERED PREFILLED SYRINGES
          • DUAL CHAMBER PREFILLED SYRINGES
        • PLASTIC PREFILLED SYRINGES
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • AUSTRALIA
      • INDIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now